Theres a New Healthy, High Protein Vegan Meat Designed for Flexitarians – LIVEKINDLY

Consumers are becoming increasingly more aware of how their food choices impact the environment and their health.

Research shows the consumption of animal products, like processed and red meat, increases the risk of certain health issues. These include heart disease, stroke, and diabetes. One study out of the University of California, Davis, found 75 percent of people have considered giving up meat for their health.

In lieu of animal products, many consumers are opting for less meat in favor of healthier, plant-based proteins. Los Angeles-based company Longve is one brand thats harnessing the power of plants to make healthier meats.

The companys CEO, Douglas Kantner, says turning 50 was a major catalyst in his health journey and ultimately inspired the companys mission and concept.

Ive always been interested in health and fitness, and have been a lifelong athleteI played football in college, he said. But when I hit 50, I found myself becoming more and more interested in what I could do to prolong my longevity.

Longve, which is a play on longevity, is revolutionizing the clean-eating market with its debut products: Gluten-Free Breadless Crumbs and Plant-Based Protein Crumblesboth of which are made from 100 percent sustainable pea protein.

Founded in 2019, Longve set out to create innovative, plant-based foods that aligned with consumers desire for good health, overall wellness, and longevity for not only themselves but for the planet, too.

With the tagline Eat for a Better Tomorrow, Today, Longve developed the worlds first shelf-stable, plant-based meat crumbles using pure-plant ingredients.

After working in the food industry for more than 30 years I decided to use my industry experience to find ways to help people find a way to put more plants on their plates, Kantner explained.

He continued, I wanted them to actually enjoy products that were plant-based, clean label and had nutritional value in a way that was more pleasurable than punishing, while also keeping an eye on planet sustainability.

The plant-based demographic has greatly expanded as more people adopt flexible eating habits. Health concerns, as well as environmental factors, have driven the popularity of the flexitarian diet.

Flexitarianismalso called the semi-vegetarian dietpromotes the consumption of plant-based foods. A flexitarian diet typically consists of vegetables, fruits, legumes, and whole grains. But it isnt as strict as vegetarian and vegan diets. So, proponents of flexitarianism may still eat animal products like meat and fish, but only in moderation.

Along with wanting to create foods that are healthy and good for the planet, the notion of flexible eating also inspires the Longve team. But they believe the definition of flexitarianism should expand to include people who simply want to eat more vegetables.

Although the companys products are plant-based, it doesnt just cater to non-meat eaters. It says it made its products to support all dietary choices and lifestyles. One of its missions is to help people achieve their health goals in the cleanest, most efficient way possible.

Longves goal is to help people easily transition to eating more plant-based foodsa goal that Kantner says the companys clean, healthy products will help them achieve.

All of our products are clean label and made with minimal ingredients and no additives. We use 100-percent sustainable pea protein as the sole ingredient in our Plant-based Protein Crumbles and Plant-Based Breadless Crumbs, and were extremely proud of the fact that theyre Project Non-GMO Certified, Certified Gluten-Free, NSF-certified Plant-Based, and soy-free, he said. That makes them one of the cleanest meat replacements on the market, and a great foundation for any flexitarian diet.

Pea protein is becoming increasingly more popular amongst manufacturers like Longve because the protein source is plant-based, better for the environment, and more economical to produce.

Pea protein is obtained from ground yellow split peas. It is a more favorable plant-based protein source because it doesnt contain common food allergens like soy or wheat. It also features a good profile of nutrients like fiber, folate, manganese, phosphorus, niacin, and copper.

Pea protein is also a complete protein. This is because it contains all nine amino acids that are essential for the human diet.

Longves plant-based ground crumbles not only taste realistic but have a similar texture to traditional ground meat.

The reaction to our Original Plant-based Protein Crumbles [has been] incrediblelots of people love the fact that [the crumbles] neutral flavor makes them a great base for their favorite recipes, Kantner said.

The CEO explained that the favorable response to the original crumbles led the company to launch two new flavors. They also created a Chopped Protein product designed to replace chopped poultry and pork in recipes.

We did, however, have lots of requests for flavored crumbles that would make it even easier to get dinner on the table during busy weeknights. Were really excited to [introduce] two flavored crumblesMasala Curry and Fiesta Tacolater this summer. Both [crumbles] come with seasoning packets to make preparation a snap. We will also be launching Chopped Protein which will replace white meats like Turkey and Pork, he said.

If the companys Instagram is anything to go by, its products are extremely versatile. It showcases the Plant-Based Protein Crumbles in a variety of dishes. These include chilis, enchilada lasagnas, tacos, and meaty spaghetti, to name a few

Chef Lee Gross says the products ease of use makes adding high-quality plant protein into dishes a breeze.

[The crumbles] can be used in a virtually endless range of applications, adaptable to almost any cuisine or cooking style I can think of. Prep is a breeze, requiring only a quick soak to be recipe-ready with a distinctive, meat-like texture, and can even be used straight from the bag in dishes such as soups and stews, he said.

The crumbles also stack up well to ground beef. One six-ounce bag of Plant-Based Protein Crumbles offers roughly the equivalent of three pounds of traditional ground meat. The crumbles also feature a high protein content. A single serving of Longves nutritious, pea protein-based Original variety contains 40 grams of protein. The Fiesta Taco and Masala Curry crumbles contain 41 and 44 grams of protein per serving, respectively.

Longves three varieties of shelf-stable Plant-Based Protein Crumbles are available to order on Amazon. Its Gluten-Free Breadless Crumbswhich come in two varieties: Panko and Plaincan also be purchased online.

To learn more about Longve, visit LongeveBrands.com.

This is a sponsored post.

Summary

Article Name

There's a New Healthy, High Protein Vegan Meat Designed for Flexitarians

Description

Flexitarians just got more vegan meat options. The plant-based company Longve is revolutionizing the clean-eating market using pea protein.

Author

Audrey Enjoli

Publisher Name

LIVEKINDLY

Publisher Logo

See more here:
Theres a New Healthy, High Protein Vegan Meat Designed for Flexitarians - LIVEKINDLY

These Lifelong Friends Just Launched a Line of Leather Goods – D Magazine

The story of luxury line Franki Ray begins three years ago, on a front porch around midnight. Stacey George and Sasha Spivey, lifelong best friends, had decided to start a company. Theyd already chosen the name Franki Ray (after their fathers) and bought the domain. They wanted to create something; they just needed to decide what, exactly, to create.

What should our email address be? Stacey George asked.

[emailprotected], Sasha Spivey suggested. And then, Spivey says, laughing as she tells the story over a glass of white wine, We just stop and look at each other and were like, Holywere going to make briefcases.

It was as simple as that. And after three years of incessant yet enjoyable toil, Spivey and George debuted a line of luxury leather briefcases, backpacks, duffel bags, jewelry rolls, and wallets last month.

Its rather a random story, really, unless you know George and Spivey. They met in kindergarten at St. Bernard of Clairvaux Catholic School, in Casa Linda, and graduated best friends from Bishop Lynch. Its almost as if our lives merged to where there wasnt a clear delineation of whose life was whose, George says. Its like, our friends. Im like, Im coming to get our dog.

They parted ways for college. George majored in political science and considered law school. Spivey majored in biomedical sciences and worked at a contract research lab, specializing in skincare; she then transitioned to plastic surgery, including laser resurfacing.

But one day, they just sat down, George recalls. Somebody said something about a bag [Spivey was] carrying, that I had given her. It was a gift bag, nothing special. [They asked,] Oh, are you guys, like making those? George laughs. I guess it looked homemade. So, were like, No, we dont make these bags. But we couldveand it would have been way better.

Which led to the brainstorming. Were sitting at my house trying to spitball a bunch of ideas to figure out what are we going to make first, Spivey says..

Neither Spivey nor George specialized in leather and manufacturing, but now they had a streamlined focus, as Spivey puts it, a target plan and idea. Theyd meet once or twice a week and sit at the kitchen table to talk about their plans and the progression. That evolved to daily texting and midnightly chats, atop their day jobs. They hadnt gone out in the past 10 months, Spivey claims, when they launched; rather, theyd sat at the kitchen table and ironed out their plans.

They used vision boards to create the bouquets and garlands that adorn the interiors of their briefcases, backpacks, and duffel bags. They photoshopped a farrago with one flower they loved, another flower they loved, a picture that inspired them, outlining the optimal color scheme and design aesthetic, then hired a professional artist to create an original computer graphic or hand-drawn image.

Spivey went so far as to create a prototypea three-dimensional vision board, if you will. She went to the thrift store, purchased old-school briefcases, spray-painted them, gutted them, and relined them with vibrant fabrics. She used the prototypes to convey Franki Rays aesthetic to the manufacturer they found after 32 rejections. Its that manufacturer who told them, We can also do other [products,] if you want. This is when the friends decided to do a whole collection: briefcases, backpacks, duffel bags, jewelry rolls, and wallets.

Despite the disparity in the shape and size of the products, certain themes crop up over and again. Robin egg blue is a favorite leather color. Roses are a favorite flower. (Theyre a nod to Abby, Spiveys biological and Georges adopted grandmother, who taught the best friends that femininity is strength). Lions are a favorite animal, appearing on the interior of briefcases and on the exterior of briefcases, jewelry rolls, and backpacks as clasps or keychains. The lion clasp equals seven months of work, the best friends nod gravely.

Its this commitment that defines Franki Ray. Spivey and George are committed to protecting the environment; hence, all leather is vegetable tanned and the bags microsuede interiors are printed with water-based pigments. Durability is equally important to the two, and all bags are made with full-grain leather, which retains the skins thick epidermis. Briefcases are made with buffalo leather, which is three times the thickness of cowhide, so that theyre tougher and more resilient. Each bag is hand-polished and rubbed with an emollient to protect against water and increase longevity. Every bag is handmade in India.

The attention to detail really [represents] our friendship, Spivey says. Were particular. We like hanging out with each other for very specific reasons and have continued to do so our whole lives because we still enjoy it.

When asked about how they anticipate the new bags will handle and hold up to daily use, Spivey and George had a good laugh. Maybe dont take it hiking in the wilderness when its snowing, George said. Added Spivey, From general human interaction with something thats nice, they should last you I dont want to say a lifetime, but maybe.

Dont tie it to your trunk like a Just Married can, she laughed. But the symbolism might be fitting. After all, says Spivey, Everything we create is a union of us.

Shop their latest styles at frankiray.com.

See the original post here:
These Lifelong Friends Just Launched a Line of Leather Goods - D Magazine

Global Precision Medicine Software Industry, Forecast to 2027 – Includes Growth Strategies and Competitive Benchmarking of Key Players -…

DUBLIN--(BUSINESS WIRE)--The "Precision Medicine Software Market by Delivery Mode (On-premise, Cloud-based), Application (Oncology, Pharmacogenomics, CNS), End User (Healthcare Providers, Research, Academia, Pharma, Biotech) - Global Forecast to 2027 " report has been added to ResearchAndMarkets.com's offering.

The global precision medicine software market is expected to grow at a CAGR of 11.8% from 2019 to 2027 to reach $2.8 billion by 2027.

The growth in the precision medicine software market is mainly attributed to the factors such as paradigm shift in treatment, rising pressure to decrease healthcare costs, scientific & technological advances in the genomics field, and growing focus towards providing companion diagnostics & biomarkers for various therapeutic areas. Moreover, emerging countries and AI in precision medicine provides significant growth opportunities for players operating in the precision medicine software market.

The precision medicine software market study presents historical market data in terms of value (2017, and 2018), current data (2019), and forecasts for 2027 - by delivery mode, application, and end user. The study also evaluates industry competitors and analyzes the market at regional and country level.

On the basis of delivery mode, the on-premise segment accounted for the largest share of the overall precision medicine software market in 2019. However, the web & cloud-based delivery mode segment is expected to grow at the faster CAGR during the forecast period, owing to its benefits, such as on-demand self-serving, no maintenance cost, low storage & upfront cost, and excessive storage flexibility. In addition, the factors such as greater security in private clouds and automated updating features of web and cloud solutions are further expected to support the rapid growth of this segment.

Based on application, the oncology segment accounted for the largest share of the overall precision medicine software market in 2019. However, the pharmacogenomics segment is expected to witness rapid growth during the forecast period. The factors such as increasing incidence of adverse drug reaction, growing focus on genomic-based study, shift from one-size-fits-all approach to personalized approach, and rising pressure on pharmaceutical companies to develop new drugs promote the fastest growth of this segment.

Based on end user, the healthcare providers segment commanded the largest share of the overall precision medicine software market in 2019. However, the pharmaceutical & biotechnological companies segment is expected to witness rapid growth during the forecast period. The factors such as increasing R&D activities related to precision medicine, increasing collaboration between pharma & biotech companies and software vendors, shift from conventional one-size-fits-all-type treatment to precision treatment, and rising R&D costs are the major factors driving rapid growth of this segment.

An in-depth analysis of the geographical scenario of the precision medicine software market provides detailed qualitative and quantitative insights about the five major geographies (North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa) along with the coverage of major countries in each region.

North America commanded the largest share of the global precision medicine software market in 2019, followed by Europe, Asia-Pacific, Latin America, and the Middle East & Africa. The factors such as well-established healthcare system in the region, rising adoption of technologically advanced products for cancer diagnosis & treatment, growing HCIT investment, government initiatives supporting developments in precision medicine, growing availability of research funding, and higher accessibility to precision medicine software are responsible for the largest share of North America in the precision medicine software market.

The key players operating in the global precision medicine software market are Syapse, Inc. (U.S.), Fabric Genomics, Inc. (U.S.), SOPHiA GENETICS SA (Switzerland), Human Longevity, Inc. (U.S.), Sunquest Information Systems Inc. (U.S.), LifeOmic Health, LLC (U.S.), Translational Software Inc. (U.S.), N-of-One (U.S.), Gene42 Inc. (Canada), PierianDx (U.S.), Foundation Medicine, Inc. (U.S.), and 2bPrecise (U.S.), among others.

Key Topics Covered

1. Introduction

1.1. Market Definition

1.2. Market Ecosystem

1.3. Currency

1.4. Key Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Insights

4.1. Introduction

4.2. Drivers

4.2.1. Paradigm Shift in Treatment

4.2.2. Rising Pressure to Decrease Healthcare Costs

4.2.3. Scientific & Technological Advances in the Genomics Field

4.2.4. Growing Focus Towards Providing Companion Diagnostics (CDx) & Biomarkers

4.3. Restraints

4.3.1. Lack of Awareness about Precision Medicine Practices

4.3.2. Fragmented Healthcare Systems in Developing Countries

4.4. Opportunities

4.4.1. Emerging Economies

4.4.2. Artificial Intelligence in Precision Medicine

4.5. Challenge

4.5.1. Lack of Reimbursement for Genetic Testing & Precision Medicine

5. Global Precision Medicine Software Market, by Delivery Mode

5.1. Introduction

5.2. On-Premise

5.3. Web & Cloud-Based

6. Global Precision Medicine Software Market, by Application

6.1. Introduction

6.2. Oncology

6.3. Pharmacogenomics

6.4. Other Applications

7. Global Precision Medicine Software Market, by End User

7.1. Introduction

7.2. Healthcare Providers

7.3. Research and Government Institutes

7.4. Pharmaceutical & Biotechnology Companies

8. Geographic Analysis

8.1. Introduction

8.2. North America

8.2.1. U.S.

8.2.2. Canada

8.3. Europe

8.3.1. Germany

8.3.2. France

8.3.3. U.K.

8.3.4. Italy

8.3.5. Spain

8.3.6. Rest of Europe (RoE)

8.4. Asia-Pacific

8.4.1. Japan

8.4.2. China

8.4.3. India

8.4.4. Rest of Asia-Pacific (RoAPAC)

8.5. Latin America

8.6. Middle East and Africa

9. Competitive Landscape

9.1. Introduction

9.2. Key Growth Strategies

9.3. Competitive Benchmarking

10. Company Profiles

(Business Overview, Strategic Developments, Product & Service Offerings, Financial Overview)

10.1. 2bprecise LLC (Part of Allscripts Healthcare Solutions Inc.)

10.2. Pieriandx, Inc.

10.3. Gene42, Inc.

10.4. Foundation Medicine, Inc.

10.5. N-Of-One, Inc. (Part of Qiagen N.V.)

10.6. Translational Software, Inc.

10.7. Syapse, Inc.

10.8. Fabric Genomics, Inc.

10.9. Sophia Genetics S.A.

10.10. Human Longevity, Inc.

10.11. Sunquest Information Systems, Inc.

10.12. Lifeomic Health, LLC

For more information about this report visit https://www.researchandmarkets.com/r/igl2sf

Go here to read the rest:
Global Precision Medicine Software Industry, Forecast to 2027 - Includes Growth Strategies and Competitive Benchmarking of Key Players -...

Adrenomyeloneuropathy Treatment Market Size, Key Trends, Challenges and Standardization, Research, Key Players, Economic Impact and Forecast to…

Complete study of the global Adrenomyeloneuropathy Treatment market is carried out by the analysts in this report, taking into consideration key factors like drivers, challenges, recent trends, opportunities, advancements, and competitive landscape. This report offers a clear understanding of the present as well as future scenario of the global Adrenomyeloneuropathy Treatment industry. Research techniques like PESTLE and Porters Five Forces analysis have been deployed by the researchers. They have also provided accurate data on Adrenomyeloneuropathy Treatment production, capacity, price, cost, margin, and revenue to help the players gain a clear understanding into the overall existing and future market situation.

Key companies operating in the global Adrenomyeloneuropathy Treatment market include _:, Ascend Biopharmaceuticals, Novadip Biosciences, Eureka Therapeutics, Human Longevity, Regeneus, Allogene Therapeutics, BioRestorative Therapies, Immatics Biotechnologies, NewLink Genetics, Cytori Therapeutics, Talaris Therapeutics

Get PDF Sample Copy of the Report to understand the structure of the complete report: (Including Full TOC, List of Tables & Figures, Chart) :

https://www.qyresearch.com/sample-form/form/1664172/global-adrenomyeloneuropathy-treatment-market

Segmental Analysis

The report has classified the global Adrenomyeloneuropathy Treatment industry into segments including product type and application. Every segment is evaluated based on growth rate and share. Besides, the analysts have studied the potential regions that may prove rewarding for the Adrenomyeloneuropathy Treatment manufcaturers in the coming years. The regional analysis includes reliable predictions on value and volume, thereby helping market players to gain deep insights into the overall Adrenomyeloneuropathy Treatment industry.

Global Adrenomyeloneuropathy Treatment Market Segment By Type:

, Steroid Replacement Therapy, Stem Cell Transplant By the end users,

Global Adrenomyeloneuropathy Treatment Market Segment By Application:

Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Adrenomyeloneuropathy Treatment market in 2020. COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets. The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future. This report also analyses the impact of Coronavirus COVID-19 on the Adrenomyeloneuropathy Treatment industry. Based on our recent survey, we have several different scenarios about the Adrenomyeloneuropathy Treatment YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Adrenomyeloneuropathy Treatment will reach xx in 2026, with a CAGR of xx% from 2020 to 2026. Global Adrenomyeloneuropathy Treatment market: Drivers and Restraints This section covers the various factors driving the global Adrenomyeloneuropathy Treatment market. To understand the growth of the market it is important to analyze the various drivers present the market. It provides data by value and volume of different regions and their respective manufacturers. This data will elaborate on the market share occupied by them, predict their revenue concerning strategies, and how they will grow in the future. After explaining the drivers, the report further evaluates the new opportunities and current trends in the market. Market restraints are factors hampering market growth. Studying these factors is equally pivotal as they help a reader need understand the weaknesses of the market. Global Adrenomyeloneuropathy Treatment market: Segment Analysis The global Adrenomyeloneuropathy Treatment market is split into two segments, type, and application. The product type briefs on the various types of products available in the market. The report also provides data for each product type by revenue for the forecast time period. It covers the price of each type of product. The other segment on the report, application, explains the various uses of the product and end-users. In the report, the researchers have also provided revenue according to the consumption of the product. Global Adrenomyeloneuropathy Treatment market: Regional Analysis The major regions covered in the report are North America, Europe, China, Rest of Asia Pacific, Central & South America, Middle East & Africa, etc. It includes revenue analysis of each region for the year 2015 to 2026. Global Adrenomyeloneuropathy Treatment market: Key Players The report lists the major players in the regions and their respective market share on the basis of global revenue. It also explains their strategic moves in the past few years, investments in product innovation, and changes in leadership to stay ahead in the competition. This will give the reader an edge over others as a well-informed decision can be made looking at the holistic picture of the market. By the therapy, the market is primarily split into, Steroid Replacement Therapy, Stem Cell Transplant By the end users, Hospitals, Clinics, Ambulatory Surgical Centers, Others

Competitive Landscape

It is important for every market participant to be familiar with the competitive scenario in the global Adrenomyeloneuropathy Treatment industry. In order to fulfil the requirements, the industry analysts have evaluated the strategic activities of the competitors to help the key players strengthen their foothold in the market and increase their competitiveness.

Key companies operating in the global Adrenomyeloneuropathy Treatment market include _:, Ascend Biopharmaceuticals, Novadip Biosciences, Eureka Therapeutics, Human Longevity, Regeneus, Allogene Therapeutics, BioRestorative Therapies, Immatics Biotechnologies, NewLink Genetics, Cytori Therapeutics, Talaris Therapeutics

Key questions answered in the report:

Enquire Customization in The Report: https://www.qyresearch.com/customize-request/form/1664172/global-adrenomyeloneuropathy-treatment-market

TOC

1 Market Overview of Adrenomyeloneuropathy Treatment1.1 Adrenomyeloneuropathy Treatment Market Overview

1.1.1 Adrenomyeloneuropathy Treatment Product Scope

1.1.2 Market Status and Outlook1.2 Global Adrenomyeloneuropathy Treatment Market Size Overview by Region 2015 VS 2020 VS 20261.3 Global Adrenomyeloneuropathy Treatment Market Size by Region (2015-2026)1.4 Global Adrenomyeloneuropathy Treatment Historic Market Size by Region (2015-2020)1.5 Global Adrenomyeloneuropathy Treatment Market Size Forecast by Region (2021-2026)1.6 Key Regions Adrenomyeloneuropathy Treatment Market Size YoY Growth (2015-2026)

1.6.1 North America Adrenomyeloneuropathy Treatment Market Size YoY Growth (2015-2026)

1.6.2 Europe Adrenomyeloneuropathy Treatment Market Size YoY Growth (2015-2026)

1.6.3 China Adrenomyeloneuropathy Treatment Market Size YoY Growth (2015-2026)

1.6.4 Rest of Asia Pacific Adrenomyeloneuropathy Treatment Market Size YoY Growth (2015-2026)

1.6.5 Latin America Adrenomyeloneuropathy Treatment Market Size YoY Growth (2015-2026)

1.6.6 Middle East & Africa Adrenomyeloneuropathy Treatment Market Size YoY Growth (2015-2026)1.7 Coronavirus Disease 2019 (Covid-19): Adrenomyeloneuropathy Treatment Industry Impact

1.7.1 How the Covid-19 is Affecting the Adrenomyeloneuropathy Treatment Industry

1.7.1.1 Adrenomyeloneuropathy Treatment Business Impact Assessment Covid-19

1.7.1.2 Supply Chain Challenges

1.7.1.3 COVID-19s Impact On Crude Oil and Refined Products

1.7.2 Market Trends and Adrenomyeloneuropathy Treatment Potential Opportunities in the COVID-19 Landscape

1.7.3 Measures / Proposal against Covid-19

1.7.3.1 Government Measures to Combat Covid-19 Impact

1.7.3.2 Proposal for Adrenomyeloneuropathy Treatment Players to Combat Covid-19 Impact 2 Adrenomyeloneuropathy Treatment Market Overview by Therapy2.1 Global Adrenomyeloneuropathy Treatment Market Size by Therapy: 2015 VS 2020 VS 20262.2 Global Adrenomyeloneuropathy Treatment Historic Market Size by Therapy (2015-2020)2.3 Global Adrenomyeloneuropathy Treatment Forecasted Market Size by Therapy (2021-2026)2.4 Steroid Replacement Therapy2.5 Stem Cell Transplant 3 Adrenomyeloneuropathy Treatment Market Overview by Therapy3.1 Global Adrenomyeloneuropathy Treatment Market Size by End Users: 2015 VS 2020 VS 20263.2 Global Adrenomyeloneuropathy Treatment Historic Market Size by End Users (2015-2020)3.3 Global Adrenomyeloneuropathy Treatment Forecasted Market Size by End Users (2021-2026)3.4 Hospitals3.5 Clinics3.6 Ambulatory Surgical Centers3.7 Others 4 Global Adrenomyeloneuropathy Treatment Competition Analysis by Players4.1 Global Adrenomyeloneuropathy Treatment Market Size (Million US$) by Players (2015-2020)4.2 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Adrenomyeloneuropathy Treatment as of 2019)4.3 Date of Key Manufacturers Enter into Adrenomyeloneuropathy Treatment Market4.4 Global Top Players Adrenomyeloneuropathy Treatment Headquarters and Area Served4.5 Key Players Adrenomyeloneuropathy Treatment Product Solution and Service4.6 Competitive Status

4.6.1 Adrenomyeloneuropathy Treatment Market Concentration Rate

4.6.2 Mergers & Acquisitions, Expansion Plans 5 Company (Top Players) Profiles and Key Data5.1 Ascend Biopharmaceuticals

5.1.1 Ascend Biopharmaceuticals Profile

5.1.2 Ascend Biopharmaceuticals Main Business and Companys Total Revenue

5.1.3 Ascend Biopharmaceuticals Products, Services and Solutions

5.1.4 Ascend Biopharmaceuticals Revenue (US$ Million) (2015-2020)

5.1.5 Ascend Biopharmaceuticals Recent Developments5.2 Novadip Biosciences

5.2.1 Novadip Biosciences Profile

5.2.2 Novadip Biosciences Main Business and Companys Total Revenue

5.2.3 Novadip Biosciences Products, Services and Solutions

5.2.4 Novadip Biosciences Revenue (US$ Million) (2015-2020)

5.2.5 Novadip Biosciences Recent Developments5.3 Eureka Therapeutics

5.5.1 Eureka Therapeutics Profile

5.3.2 Eureka Therapeutics Main Business and Companys Total Revenue

5.3.3 Eureka Therapeutics Products, Services and Solutions

5.3.4 Eureka Therapeutics Revenue (US$ Million) (2015-2020)

5.3.5 Human Longevity Recent Developments5.4 Human Longevity

5.4.1 Human Longevity Profile

5.4.2 Human Longevity Main Business and Companys Total Revenue

5.4.3 Human Longevity Products, Services and Solutions

5.4.4 Human Longevity Revenue (US$ Million) (2015-2020)

5.4.5 Human Longevity Recent Developments5.5 Regeneus

5.5.1 Regeneus Profile

5.5.2 Regeneus Main Business and Companys Total Revenue

5.5.3 Regeneus Products, Services and Solutions

5.5.4 Regeneus Revenue (US$ Million) (2015-2020)

5.5.5 Regeneus Recent Developments5.6 Allogene Therapeutics

5.6.1 Allogene Therapeutics Profile

5.6.2 Allogene Therapeutics Main Business and Companys Total Revenue

5.6.3 Allogene Therapeutics Products, Services and Solutions

5.6.4 Allogene Therapeutics Revenue (US$ Million) (2015-2020)

5.6.5 Allogene Therapeutics Recent Developments5.7 BioRestorative Therapies

5.7.1 BioRestorative Therapies Profile

5.7.2 BioRestorative Therapies Main Business and Companys Total Revenue

5.7.3 BioRestorative Therapies Products, Services and Solutions

5.7.4 BioRestorative Therapies Revenue (US$ Million) (2015-2020)

5.7.5 BioRestorative Therapies Recent Developments5.8 Immatics Biotechnologies

5.8.1 Immatics Biotechnologies Profile

5.8.2 Immatics Biotechnologies Main Business and Companys Total Revenue

5.8.3 Immatics Biotechnologies Products, Services and Solutions

5.8.4 Immatics Biotechnologies Revenue (US$ Million) (2015-2020)

5.8.5 Immatics Biotechnologies Recent Developments5.9 NewLink Genetics

5.9.1 NewLink Genetics Profile

5.9.2 NewLink Genetics Main Business and Companys Total Revenue

5.9.3 NewLink Genetics Products, Services and Solutions

5.9.4 NewLink Genetics Revenue (US$ Million) (2015-2020)

5.9.5 NewLink Genetics Recent Developments5.10 Cytori Therapeutics

5.10.1 Cytori Therapeutics Profile

5.10.2 Cytori Therapeutics Main Business and Companys Total Revenue

5.10.3 Cytori Therapeutics Products, Services and Solutions

5.10.4 Cytori Therapeutics Revenue (US$ Million) (2015-2020)

5.10.5 Cytori Therapeutics Recent Developments5.11 Talaris Therapeutics

5.11.1 Talaris Therapeutics Profile

5.11.2 Talaris Therapeutics Main Business and Companys Total Revenue

5.11.3 Talaris Therapeutics Products, Services and Solutions

5.11.4 Talaris Therapeutics Revenue (US$ Million) (2015-2020)

5.11.5 Talaris Therapeutics Recent Developments 6 North America Adrenomyeloneuropathy Treatment by Players and by End Users6.1 North America Adrenomyeloneuropathy Treatment Market Size and Market Share by Players (2015-2020)6.2 North America Adrenomyeloneuropathy Treatment Market Size by End Users (2015-2020) 7 Europe Adrenomyeloneuropathy Treatment by Players and by End Users7.1 Europe Adrenomyeloneuropathy Treatment Market Size and Market Share by Players (2015-2020)7.2 Europe Adrenomyeloneuropathy Treatment Market Size by End Users (2015-2020) 8 China Adrenomyeloneuropathy Treatment by Players and by End Users8.1 China Adrenomyeloneuropathy Treatment Market Size and Market Share by Players (2015-2020)8.2 China Adrenomyeloneuropathy Treatment Market Size by End Users (2015-2020) 9 Rest of Asia Pacific Adrenomyeloneuropathy Treatment by Players and by End Users9.1 Rest of Asia Pacific Adrenomyeloneuropathy Treatment Market Size and Market Share by Players (2015-2020)9.2 Rest of Asia Pacific Adrenomyeloneuropathy Treatment Market Size by End Users (2015-2020) 10 Latin America Adrenomyeloneuropathy Treatment by Players and by End Users10.1 Latin America Adrenomyeloneuropathy Treatment Market Size and Market Share by Players (2015-2020)10.2 Latin America Adrenomyeloneuropathy Treatment Market Size by End Users (2015-2020) 11 Middle East & Africa Adrenomyeloneuropathy Treatment by Players and by End Users11.1 Middle East & Africa Adrenomyeloneuropathy Treatment Market Size and Market Share by Players (2015-2020)11.2 Middle East & Africa Adrenomyeloneuropathy Treatment Market Size by End Users (2015-2020) 12 Adrenomyeloneuropathy Treatment Market Dynamics12.1 Industry Trends12.2 Market Drivers12.3 Market Challenges12.4 Porters Five Forces Analysis 13 Research Finding /Conclusion 14 Methodology and Data Source 14.1 Methodology/Research Approach

14.1.1 Research Programs/Design

14.1.2 Market Size Estimation

14.1.3 Market Breakdown and Data Triangulation14.2 Data Source

14.2.1 Secondary Sources

14.2.2 Primary Sources14.3 Disclaimer14.4 Author List

About Us:

QYResearch always pursuits high product quality with the belief that quality is the soul of business. Through years of effort and supports from huge number of customer supports, QYResearch consulting group has accumulated creative design methods on many high-quality markets investigation and research team with rich experience. Today, QYResearch has become the brand of quality assurance in consulting industry.

Read the original post:
Adrenomyeloneuropathy Treatment Market Size, Key Trends, Challenges and Standardization, Research, Key Players, Economic Impact and Forecast to...

COVID-19: Learn the virtues of patience from great cricketers – Gulf News

Sachin Tendulkar leaves a delivery outside the off stump during his playing days. Image Credit: AFP

Staying at home and maintaining hygiene are two important to dos for all to remain safe from the coronavirus disease. But to practice this, one needs tremendous patience and discipline. The game of cricket teaches these two traits, and most great players have these two qualities in abundance in them.

Staying on the batting crease and keep scoring runs do not come through sheer inborn talent alone. We have often heard about cricketers with great skills but repeatedly failing to post big scores.

During an interview with the legendary Sachin Tendulkar for the Friday Magazine, the Little Master told me: Discipline, focus, desire, passion, and fitness are a must if you want to achieve any form of longevity in any field. A disciplined and dedicated effort is what I followed.

At a time when coronavirus is threatening the longevity of everyones life, these qualities are ideal to be emulated. Even bowlers need these traits to be successful. Indias leg spinner Yuzvendra Chahal is a chess player turned cricketer and hed recently remarked that chess had taught him that even if he didnt get a wicket during a full day of a Test match, he could come back and get wickets the next day. Patience and the hope that the COVID-19 threat will end soon are vital; one cannot get disheartened during this phase.

Everyone has stressed on the importance of being mentally strong during this phase. Sunil Gavaskar, who spoke to Gulf News recently on the need to be mentally strong, is an embodiment of that. Had he been intimidated by the huge, well-built fast bowlers of West Indies, he would never have become the first man to reach the 10,000 Test runs in cricket.

Fear about the future and negativity are something that can grip anyone, especially when staying at home without interacting with people. The famous saying that an idle mind is a devils workshop can turn into reality during this phase. It is during such phases that one should visualise success and dream of achieving glory as soon as this crisis gets over.

This is the right time for everyone to try and read inspiring tales of sportsmen. Sport is about human endurance and the stories you may read are mostly about how sportsmen achieved success through determination.

Many young cricketers complain about not getting selected and on the lack of facilities that have hindered their progress. This is the time get rid of that habit - once and for all. Read an autobiography of a cricketer and there you will see how he managed to ride the toughest of odds to be successful.

This is not the time to complain as to how unlucky you are to be affected by this crisis. Remember, luck has always favoured the brave and the determined!

Here is the original post:
COVID-19: Learn the virtues of patience from great cricketers - Gulf News

Adrenomyeloneuropathy Treatment Market: Strategic Analysis to Understand the Competitive Outlook of the Industry, 2025 – Science In Me

The Adrenomyeloneuropathy Treatment Market globally is a standout amongst the most emergent and astoundingly approved sectors. This worldwide market has been developing at a higher pace with the development of imaginative frameworks and a developing end-client tendency.

Adrenomyeloneuropathy Treatment market reports deliver insight and expert analysis into key consumer trends and behaviour in marketplace, in addition to an overview of the market data and key brands. Adrenomyeloneuropathy Treatment market reports provides all data with easily digestible information to guide every businessmans future innovation and move business forward.

Request Sample Report @ https://www.persistencemarketresearch.co/samples/28645

The worldwide Adrenomyeloneuropathy Treatment market is an enlarging field for top market players,

key players and government is expected to spur the adrenomyeloneuropathy treatment market.

The North America market for adrenomyeloneuropathy treatment is expected to retain its dominance, owing to increasing patient pool for rare disease, increasing government funding to accelerate the research and development for rare disease. According to Genetic and Rare Diseases Information Center, more than 25 million Americans are suffering from rare disease in United States.Europe is expected to account for the second largest share in the global adrenomyeloneuropathy treatment market owing to growing clinical trial funding programs for orphan drug development and high prevalence of adrenomyeloneuropathy and high treatment seeking rate. Asia Pacific is expected to show significant growth, owing to increasing diagnosis rate and improvement in healthcare infrastructure. China is expected to show significant growth in the adrenomyeloneuropathy treatment market, due to rising population improving R&D capability, increasing per capita heath spending. Latin America and Middle East & Africa is expected to show growth owing to lack of diagnosis and inadequate healthcare facilities and lack of skilled physicians for Adrenomyeloneuropathy Treatment market.

Examples of some of the key manufacturer present in the global adrenomyeloneuropathy treatment market are Ascend Biopharmaceuticals, Novadip Biosciences, Eureka Therapeutics, Human Longevity, Regeneus, Allogene Therapeutics, BioRestorative Therapies, Immatics Biotechnologies, NewLink Genetics, Cytori Therapeutics, Talaris Therapeutics among others.

The report covers exhaustive analysis on,

Regional analysis includes

Report Highlights:

Request Report Methodology @ https://www.persistencemarketresearch.co/methodology/28645

This Adrenomyeloneuropathy Treatment report begins with a basic overview of the market. The analysis highlights the opportunity and Adrenomyeloneuropathy Treatment industry trends that are impacted the market that is global. Players around various regions and analysis of each industry dimensions are covered under this report. The analysis also contains a crucial Adrenomyeloneuropathy Treatment insight regarding the things which are driving and affecting the earnings of the market. The Adrenomyeloneuropathy Treatment report comprises sections together side landscape which clarifies actions such as venture and acquisitions and mergers.

The Report offers SWOT examination and venture return investigation, and other aspects such as the principle locale, economic situations with benefit, generation, request, limit, supply, and market development rate and figure.

Quantifiable data:-

Geographically, this report studies the top producers and consumers, focuses on product capacity, production, value, consumption, market share and growth opportunity in these key regions, covering North America, Europe, China, Japan, Southeast Asia, India

For any queries get in touch with Industry Expert @ https://www.persistencemarketresearch.co/ask-an-expert/28645

Research objectives and Reason to procure this report:-

Finally, the global Adrenomyeloneuropathy Treatment market provides a total research decision and also sector feasibility of investment in new projects will be assessed. Adrenomyeloneuropathy Treatment industry is a source of means and guidance for organizations and individuals interested in their market earnings.

View original post here:
Adrenomyeloneuropathy Treatment Market: Strategic Analysis to Understand the Competitive Outlook of the Industry, 2025 - Science In Me

Only the toughest ginseng – Bangkok Post

Korean culture has globally disseminated through K-beauty as much as K-pop and K-drama have.

The history of Whoo harks back to the royal court of the Joseon Dynasty, in developing the Royal Privilege Cream, majestically priced at 70,500 baht.

Its launch in Bangkok was accompanied by an exhibition about the luxury brand, under LG Household & Healthcare.

Whoo refers to an empress whose age-old beauty secrets, along with records of the court's medical manuals, have been reinterpreted into modern-day cosmetics.

The logo recalls the haegeum, a traditional instrument that maintains harmony and balance of wind and string instruments. This reflects how its beauty products restore the balance of the skin.

Like how traditional Korean medicine prescribes ginseng as a panacea, the K-beauty brand swears by the medicinal herb as a powerful skincare ingredient.

Royal Privilege Cream powered by extracts of the wild ginseng family and flower.

The hefty price tag of the new face cream is due to Royal Empress Wild Ginseng -- a blend of extracts from different parts of a precious type of wild ginseng, Wang Whoo Sam, found in the northeastern part of the Baekdudaegan Mountain Range.

Crowned the Queen of Wild Ginseng, it grows as a family comprising mother and offspring with a strong vitality and longevity lineage. Only the toughest mother ginseng is able to deliver the baby ginseng, which further makes them a rare find in nature.

Common wild ginseng generally dies after 20-30 years, but this variety, as a group, lives twice as long, for 40-50 years. Moreover, it contains a high amount of active substances, for promoting healthy skin.

The Royal Privilege Cream also contains an extract from wild ginseng flowers, endowed with more phytocompounds than those found in the roots.

The inflorescence fully blooms from 8-10am, for only two to three days in a year, between mid May to June, when it is picked to capture the concentrated vital energy.

Likewise, the human body depends on a life force energy and a strong immune system that improves overall skin health.

The formulation of the Royal Privilege Cream is based on this principle, termed Dae-Bo-Won-Gi, which emphasises a fully-charged "original energy" in order to maintain a harmonious circulation of blood, vital energy and essence for healthy body and skin.

The Royal Privilege Pact comes with three applicators for different effects. The history of Whoo

From oriental medicine records, the researchers also learned of the cocoon's efficacy in softening the skin and how it was burned to release its medicinal properties.

This led to adding a silk protein, Sericin, to enrich the Royal Privilege Cream with nutrients while smoothening the texture of the formula.

The luxurious cream is housed in a handcrafted jar and box, inspired by a jade investiture book, appointment edict and gold seal engraved with the title, bestowed to a Korean empress in a royal coronation.

The regal cream was unveiled along with the Royal Privilege Pact, presented in a compact, evoking a jewellery box, with similar delicate metalwork and regal motif.

The pressed powder claims to contain traces of platinum, gold, sapphire, coral, pearl, ruby, diamond and amber, which justifies its price of over 27,500 baht.

See the rest here:
Only the toughest ginseng - Bangkok Post

5 free games to cure cabin fever as you wait out the Covid-19 pandemic – The Straits Times

The World Health Organisation last week recommended playing video games as a healthy way of physical distancing while maintaining social connection in the midst of the coronavirus pandemic.

However, there are many people who are not gamers or do not want to spend money on games.

So here are five free-to-play games - some with the option of in-app purchases - to consider as we stay home and wait out this wretched pandemic.

Available on PC

If you are a Star Wars fan, playing Star Wars: The Old Republic is a great way to kill time with some familiar galactic action.

This game is a massively multiplayer online role-playing game, so it is best to get some friends on board. However, it is possible to play alone without teaming up with anyone to complete quests and level up.

You can choose between the path of a Jedi or a Sith. And, of course, expect to wield a lightsaber or two.

Available on PC, PS4 and Xbox One

PHOTO:ACTIVISION

Fancy a last-man-standing battle? Warzone offers that with its Battle Royale mode, in which each match can have up to 150 players - trumping the 100-player limit in PlayerUnknown's Battlegrounds, one of the most popular games of this genre.

Warzone comes with the rich heritage of the Call Of Duty game franchise, and has both solo and team play options in its Battle Royale mode.

Its other main mode is the Blood Money mode, in which teams have to search for cash around a game map to accumulate as much money as possible. The team with the most money wins the game.

Available on PC, PS3 and Xbox 360

PHOTO:VALVE

Sometimes old is gold. Counter-Strike: Global Offensive might be nearly eight years old, but there are still a lot of people playing the game. According to statistics from online video game retailer Steam, more than one million gamers played it concurrently on March 14.

Its longevity lies in its simplicity. This first-person shooter game pits two teams of five against each other.

One team, the Terrorists, needs to plant a bomb or defend hostages, while the other team, the Counter-Terrorists, needs to defuse the bomb or rescue hostages. Your team wins when the objectives are met or when you kill everyone in the opposing team.

Available on PC, Mac and Linux

PHOTO:UNIVERSITY OF WASHINGTON

A game with a premise apt for these times, Foldit is a free puzzle game, developed by researchers at the University of Washington, about killing the coronavirus.

The game was first released in 2008. In 2011, Foldit players helped scientists solve a problem about decoding the Aids virus.

In this update of the game, you will be tasked with creating or modifying protein chains so they can bind to the coronavirus' distinct spike protein, thus preventing the latter from infecting human cells.

While it might sound like rocket science, the puzzle is simple. You just need to fold an existing protein into a new shape that potentially blocks the spike protein.

You earn points based on your protein's efficiency in blocking the spike protein. Download Foldit here.

Available on Android and iOS

PHOTO:ZYNGA

In this Scrabble-like multiplayer word game, players take turns to build words on a crossword puzzle-style board.

Each player has seven randomly generated letter tiles. These tiles will be replenished until all 104 tiles have been used. Players take turns to form words on the board and can choose to swop tiles with the pool of currently unused tiles, or skip a turn if they cannot form a word.

Read the rest here:
5 free games to cure cabin fever as you wait out the Covid-19 pandemic - The Straits Times

Stephen Colton’s Take on Nature: Ancient harts-tongue fern catches the eye – The Irish News

I'VE been thinking lately how much we take our senses for granted, those windows to the world, and how the treadmill of living dulls our appreciation of experiences they give us.

Most days I walk familiar routes, passing similar landmarks; a bend in the river, a particular tree, banks or hedgerows. Such repetition brings complacency when looking at certain things along well-trodden paths.

A fern whose lineage, according to fossil records, stretches back to around 360 million years ago is a plant I've given a frequent glance, but have neglected to properly acknowledge.

It took the presence of a grey wagtail, dancing and bobbing nearby recently, to prompt my first serious consideration of the native Hart's-tongue, as it hung in clusters from the damp rocky crevices of the riverbank, its undivided fronds, glossy green and shiny.

The tongue-shaped pointed leaves along with hart', the name for an older male red deer, give rise to its name, resembling a deer's tongue' or teanga fia' in Irish.

Some other names have been noted for the fern such as cow tongue' (Hart, 1898) and fox's tongue' (Colgan 1904).

The sporangia which produce and contain the spores are arranged in lines along the underside of the leaves resembling a centipede's legs, hence the species name 'scolopendrium', Latin for centipede. Ferns reproduce by releasing these spores and have neither seeds nor flowers.

Though battered by recent storms and fluctuating water levels, the arching leaves of these ferns will soon be replaced by new luxuriant blades unfurling in late spring.

Hart's-tongue, which prefers woodlands, hedgerows and damp shady places, is just one of the many fern varieties found in Ireland. Their graceful feathery fronds have fascinated poets and writers for centuries. In his poem The Stolen Child (1886) WB Yeats, reaching for the innocence of childhood again, writes of the lure by the fairies:

"Leaning softly out?From ferns that drop their tears?Over the young streams" to

"Come away, O human child!?To the waters and the wild'".

Another giant of the Romantic poets, Coleridge in an early version of the poem This Lime-Tree Bower my Prison (1797), writes of "the ferny rock/Whose plumy ferns forever nod and drip". He later wrote in one of his notebooks, "An eminently beautiful object is Fern".

In the Irish legend of Mad Sweeney, the outcast King castigates fern, saying "There is no bed for an outlaw/In the branches of thy crests".

Like many plants with such longevity, hart's tongue has been used for medicinal purposes by past communities to treat coughs, digestive problems and open wounds.

Culpeper's Complete Herbal (1653), still in print today, said of the plant, "Hart's Tongue is much commended against the hardness and stoppings of the spleen and liver, and against the heat of the liver and stomach, and against the bloody-flux. Dioscorides [a Greek physician] saith, it is good against stinging or biting of serpents."

A record from Co Limerick in a manuscript of the Irish Folklore Commission tells how hart's-tongue leaf was burned and applied to cure burns. It is also thought that fern was used to brew ale in early Ireland. In the Lebor Gabla, or Book of Invasions, Malaliach is said to have been the first brewer in Ireland making lind ratha or fern ale'.

The male grey wagtail showed off its black throat and bright yellow underside as it moved along the river bank in search of food, before flying off downstream, in undulating pattern low above the water and out of sight, its job of drawing me towards the fern, now done. Keep well.

Read more:
Stephen Colton's Take on Nature: Ancient harts-tongue fern catches the eye - The Irish News

The race for a coronavirus vaccine – The Week

Researchers are working frantically on a shot that would immunize people against Covid-19. Why does it take so long? Here's everything you need to know:

Is a vaccine close?Despite the global competition to develop a coronavirus vaccine, experts agree one won't be available for at least 12 to 18 months. The race kicked off Jan. 10, when Chinese scientists published the complete 30,000-letter genetic code of SARS-CoV-2, the novel coronavirus that causes COVID-19. That allowed scientists to make synthetic versions of the virus rather than waiting for sample shipments, and roughly 80 pharma giants, small labs, and government entities began chasing a cure. Moderna, a biotech startup in Cambridge, Massachusetts, produced a vaccine candidate that was injected into the arm of a 43-year-old Seattle mother in mid-March, smashing the world record for fastest human testing. Several other labs have since launched clinical trials. President Trump pledged to "slash red tape" slowing development, but scientists say it's not bureaucracy or pointless rules that make his request for a vaccine by summertime impossible.

What's the holdup?Before injecting a vaccine into millions of people, scientists need to conduct tests to prove that it actually protects against a specific pathogen and doesn't have serious side effects. Under normal circumstances, a vaccine can take a decade to get FDA approval. Coronavirus research is racing along, thanks largely to the Coalition for Epidemic Preparedness Innovations (CEPI), a Norway-based organization founded in 2017 to help labs like Moderna plan for "prototype" pathogens. Yet although scientists are desperate to save lives, cutting corners could have treacherous consequences. (Extremely ill patients can get unproven treatments under "compassionate use" exceptions, but vaccines are administered to people before they get sick.) A vaccine for swine flu in 1976 gave hundreds of people a rare nerve disorder, and a vaccine for H1N1 bird flu in 2009 caused some Europeans to develop narcolepsy. Some failed vaccines have made recipients more vulnerable to the disease. A candidate vaccine for SARS was abandoned after it made mice more likely to die.

How is a vaccine created?There are no existing vaccines for coronaviruses, but new technology is accelerating the process; three hours after China published the COVID-19 genome, Inovio Pharmaceuticals in San Diego used a computer algorithm to produce a vaccine blueprint. Preventive vaccines use dead or weakened pathogens to prime the immune system to fight diseases in the case of COVID-19, by teaching it to recognize the coronavirus protein's "spikes" that latch onto cells. That recognition cues white blood cells to produce antibodies that can fight a real infection. Moderna is pursuing an original approach: injecting messenger RNA (mRNA) molecules that encode instructions for building coronavirus-like proteins, so they can be recognized as foreign threats.

How long will testing take?Clinical trials usually occur in three phases. First, about 50 healthy human volunteers are paid $1,100 each to be injected with a candidate vaccine, and then monitored to see if they produce antibodies without unintended side effects. If that's successful, a few hundred people get the vaccine, and their immune response and side effects are carefully studied. In phase three, several thousand people are tested: Half get the vaccine, half get a placebo; if vaccinated subjects don't get sick or get sick at much lower rates, the vaccine is ready for FDA approval. This all can take eight to 12 months. If and when a coronavirus vaccine is approved, other problems immediately arise: Who gets it first? And who pays for vaccinations if people are uninsured? Manufacturing billions of vaccine doses will take months, and rich nations could hoard limited supplies. Vaccinating every American could cost $165 billion, Time estimates.

What are the top contenders?Some of the most promising vaccines build on proven science. Janssen, the Belgian pharmaceutical subsidiary of Johnson & Johnson, is developing a vaccine modeled on the successful vaccine for Ebola. Inovio, the San Diegobased company, and Maryland-based Novavax are modeling vaccines on candidates in advanced trials for MERS, a coronavirus disease similar to COVID-19. In China, 1,000 scientists are working on a vaccine and launching more than 200 clinical trials to test everything from anti-flu drugs to ancient Chinese herbal medicine. Moderna's mRNA approach is also being used by the German company CureVac; German government officials accused Trump of trying to poach CureVac scientists and their intellectual property for the exclusive use of the U.S.

What's a realistic timeline?There are dozens of vaccines in the pipeline, but COVID-19 cases are expected to peak in the U.S. months before any of them is approved. Scientists raced to find vaccines for SARS, in the early 2000s, and MERS, in 2012, only to shelve their work when those outbreaks were contained. Experts have grimmer expectations for the longevity of coronavirus, meaning a vaccine ready a year from now could still save many millions of lives. With a large number of people getting sick and dying, the race for a vaccine requires a painful amount of patience. "I'm going to bed thinking we made some progress," Moderna president Stephen Hoge says, "and waking up every morning feeling further and further behind."

Promising treatments A treatment that lessens the impact of COVID-19 is expected to come before a vaccine, but doctors on the front lines warn against high hopes. "We have no idea what works or does not at this point," says Andre Kalil, an infectious-disease physician at the University of Nebraska Medical Center. Kalil is leading U.S. clinical trials for one of the most promising treatments, the antiviral drug remdesivir, which was developed for Ebola. In February, an American passenger on the Diamond Princess cruise ship who contracted coronavirus after the ship docked in Japan became Kalil's first volunteer. Other antivirals being researched are already in use for HIV and malaria. Other tests focus on drugs for lung inflammations, and antibody-based treatments, including using antibody-rich blood serum taken from coronavirus survivors. A survivor can spare enough serum for one to 10 people. A Johns Hopkins University team got FDA approval in mid-March to test this approach. "This is real," team leader Arturo Casadevall says. "In eight weeks, we may have something that's useful."

This article was first published in the latest issue of The Week magazine. If you want to read more like it, try the magazine for a month here.

See the article here:
The race for a coronavirus vaccine - The Week

Incredible Growth of Anti-Senescence Therapy Market 2020 Growing with Major Eminent Key Players Unity Biotechnology, Siwa Therapeutics, Calico LLC,…

The Global Anti-Senescence Therapy Market report scope covers an in-depth business analysis considering major market dynamics, forecast parameters, and price trends for industry growth. The study offers marketers to be updated with existing trends and the relevant competitors operating in the market. The report forecasts market sizing at global, regional and country levels, providing a comprehensive outlook of emerging and existing industry trends in each market segment and sub-segment from 2020 to 2026.

The report outlines an overview of the industry chain structure and describes the upstream. All the questions which border on the growth spectrum, shortcomings, key players, strategies, market size, recent developments, company profiles with regards to Global Anti-Senescence Therapy Market are answered in this report. Analysis trend & forecasts by end-use markets will help you to understand how the growth in consumption is expected to shape up in the next 5 years and what will be the key factors rendering the growth. This will help to formulate a clear plan for top-line growth. Price analytics is also expected to play a crucial role in devising a plan for top-line growth.

Click Here To Access The Sample Report: https://www.acquiremarketresearch.com/sample-request/306636/

Major Market Players Covered In This Report: Unity Biotechnology, Siwa Therapeutics, Calico LLC, AgeX TherapeuticsInc, Numeric Biotech, Human Longevity Inc. (HLI), Cleara Biotech, OisinBiotechnologies, Recursion Pharmaceuticals, Sierra Sciences, Proteostasis Therapeutics, Senolytic Therapeutics, Allergan

The key product type of Anti-Senescence Therapy market are: Gene Therapy, ImmunOther

Anti-Senescence Therapy Market Outlook by Applications: Cardiovascular Diseases, Neural Degenerative Diseases, Ophthalmology Disorders, Other

In a competitive marketplace, updated information can make the difference between keeping pace, getting ahead, and being left behind. We also furnish you with information that allows you to anticipate what your competitors are planning next. We have provided a long list of customers and analyzed them critically, based on various parameters such as consumption, market type, sustainable business, etc. which is likely to help your organization foster sustainable relations with the consumers. Furthermore, we have identified the factors that can drive other customers towards your business.

To Get This Report At Beneficial Rates: https://www.acquiremarketresearch.com/discount-request/306636/

Global Anti-Senescence Therapy Market Pin-Points: Anti-Senescence Therapy report documents the historical rise of the foremost dominant region that guides the Anti-Senescence Therapy reader to line up effective long investment judgments; The Anti-Senescence Therapy report covers forecast information from 2020 2026 of the aforementioned market sections and sub-segments that earn considerable share; The study encompasses the previous, present and estimable size of this world Anti-Senescence Therapy marketplace for the degree and value; It provides key math information on the position of this world Anti-Senescence Therapy trade, the market volumes and forecast market estimation for 2020 2026; The intensive approach towards Anti-Senescence Therapy market drivers, constraints, chances, and trends driving the market, that can further assist in creating rewarding business plans;

In this Anti-Senescence Therapy market study, the following years are considered to project the market footprint: History Year: 2015 2020 Base Year: 2015 Estimated Year: 2026 Forecast Year: 2020 2026

Benefits of Purchasing Anti-Senescence Therapy Market Report: Analyst Support: Get your queries resolved from our expert analysts before and after purchasing the report. Customers Satisfaction: Our expert team will assist with all your research needs and customize the report. Inimitable Expertise: Analysts will provide deep insights into the reports. Assured Quality: We focus on the quality and accuracy of the report.

To Know More About The Assumptions in This Market Report: https://www.acquiremarketresearch.com/industry-reports/anti-senescence-therapy-market/306636/

Request customized copy of Anti-Senescence Therapy reportIf you wish to find more details of the report or want customization, contact us. You can get a detailed of the entire research here. If you have any special requirements, please let us know and we will customize the report as you want.

To summarise, the Anti-Senescence Therapy Market report includes investment come analysis and development trend analysis. The present and future opportunities of the fastest growing international industry segments are coated throughout this report. This report additionally presents product specification, manufacturing method, and product cost and price structure.

Read more here:
Incredible Growth of Anti-Senescence Therapy Market 2020 Growing with Major Eminent Key Players Unity Biotechnology, Siwa Therapeutics, Calico LLC,...

Milton Security Group Partners with SynED to Strengthen the Cyber Workforce in California – Yahoo Finance

FULLERTON, Calif., Feb. 26, 2020 /PRNewswire/ -- Milton Security Group, Inc., a leading cybersecurity company specializing in 24*7 cyber threat hunting, monitoring, and incident response, announced today a new partnership with SynED to increase professional employment opportunities throughout the cybersecurity industry. This partnership leads the way for this effort in Orange County, CA.

SynED is a non-profit organization working with educational institutions, training partners, placement agencies and service providers to increase a strong and highly skilled workforce throughout California.

"This partnership codifies one of Milton Security's core values, helping others, since our founding 13 years ago. Our goal is to help even more people enter the cybersecurity industry and we have established a successful legacy by hiring individuals who do not fit a traditional mold. We seek out the passionate, the unconventional, the veteran and invest in them through hands-on experiences. The longevity of our team and collective performance has created significant organic growth and advancement opportunities for our team members," said James McMurry, CEO and Founder of Milton Security.

"Through strong partnerships, like we have with Milton Security, we will build the foundation of a new approach for developing a robust cybersecurity talent supply chain and subsequently strengthening the overall security of our nation," said Scott Young, President of synED. "We are thrilled to work with such passionate and visionary partners."

Milton Security and SynED have established a baseline of skills to evaluate and further develop cybersecurity candidates. Milton Security will share this knowledge to assist other organizations in placing their candidates and building a stronger cybersecurity workforce.

Ethan Coulter, President of Milton Security said: "We help passionate people find their path into this industry. This not only benefits professionals seeking to enter our industry, but our customers as well, and yes, even our competitors. We are proud to take part in this program and push our industry forward."

Story continues

About Milton Security Group, Inc.:

Milton Security Group, Inc., is a Service-Disabled Veteran-Owned Small Business started in 2007.

Milton Security operates a 24*7*365 Managed Detection and Response (MDR) service that provides Threat Hunting As A Service using customers' existing security infrastructure. Using a combination of AI, ML, and human correlation, Milton Threat Hunters scout for threats and assists with incident response activities in real time 24 hours a day. According to a recent report by Gartner, "Managed detection and response services allow organizations to add 24/7 dedicated threat monitoring, detection and response capabilities via a turnkey approach." Milton Security MDR goes above and beyond this by active threat hunting, not just monitoring.

http://www.miltonsecurity.com| +1.888.714.9001 | 234980@email4pr.com

About SynED

SynED is a non-profit organization dedicated to promoting educational excellence by providing higher education professional services to facilitate the development of new models of curriculum, industry alliance, service, and delivery.

SynED has teamed up with the California-based organizations and focused program with the goal of building new and innovative talent and retention programs for companies participating in the defense supply chain. SynED's goal is to help the entire industry leverage their collective skills and resources to increase the number of qualified and career ready professionals.

https://syned.org/| 866.420.4573 xt801 | info@syned.org

Media Contact:

Lydia Coulter

714-515-4011

234980@email4pr.com

View original content to download multimedia:http://www.prnewswire.com/news-releases/milton-security-group-partners-with-syned-to-strengthen-the-cyber-workforce-in-california-301012117.html

SOURCE Milton Security

Link:
Milton Security Group Partners with SynED to Strengthen the Cyber Workforce in California - Yahoo Finance

GoNNER and Offworld Trading Company are free on the Epic Games Store – PC Gamer

Epic's barrage of freebies continues today with GoNNER and Offworld Trading Company, both scratching very different itches. GoNNER is a procedurally-generated roguelike platformer, while Offworld Trading Company is an economic RTS set on Mars.

Offworld Trading Company is very much my jam, even though it makes me feel dirty. It's an unconventional RTS where battles take place in the marketplace, with corporations trying to muscle each other out of the lucrative planet. Even without armies, it's still a fast-paced, competitive affair, and somehow watching market fluctuations is just as exciting as watching armies colliding. OK, almost as exciting. The AI is fine, but it's made even better by sneaky human opponents.

I try to avoid torturing myself with roguelike platformers, so I'll let Phil Savage's GoNNER review fill you in.

Despite GoNNER's difficulty, aesthetic and mystery, there isn't a whole lot to it. It doesn't take long to work out an enemy's patterns, and there's isn't much variety within the level generation. While loadouts offer some tactical planning, the range of equipment isn't as diverse or significant as, for instance, Nuclear Throne. GoNNER doesn't offer the longevity of the best roguelike shooters, but it's nonetheless a stylish, weird and entertaining action platformer.

They're both free until March 12 at 3 pm GMT/7 am PT, when they'll be replaced by a trio of new games: Anodyne 2, A Short Hike and Mutazione.

Read more:
GoNNER and Offworld Trading Company are free on the Epic Games Store - PC Gamer

As the World Lives Longer, Investment in Early Healthcare is Paramount – Qrius

Looking back 150 years, the proportion of elderly in Japans population was only a few per cent; now it exceeds 27%, making Japan the worlds top super-aged society.In 2060, it will exceed 38% and remain at this level in the future, retaining its top spot. OECD countries and many emerging economies including China will follow suit at their own respective speeds. The transition is a great outcome of public health and medicine.

A super-aged society is a natural consequence of longevity and we should celebrate it; on the other hand, our new challenge is healthy longevity or how we can be healthy, active and happy until the very end of our lives. Japanese data on the elderly, gathered byDr Hiroko Akiyama of the University of Tokyo, suggests that health status at 65 is a strong indication of quality of life for the rest of life. In the 70-year-lifespan model, where people die in their 60s or 70s, health is not as big an issue for working-age people; in the 100-year lifespan model, one should continuously invest in ones health from as early a point as possible to maintain ones health after retirement. But how?

The Fourth Industrial Revolution offers good news on this front. Now, it is much easier than ever before to gather indicators of what affects ones health. We can gather genomic data, daily vitality data, health check data and medical treatment data. We can also gather data regarding lifestyle, social connectedness and financial activity all at a lower cost. Then artificial intelligence (AI), the Internet of Things (IoT) and Big Data analysis can help us to understand our health more accurately and easily, and maintain it cost-effectively. We have rich new solutions for healthier lives.

The issue is the motivation or incentive for ordinary people to invest in their health before becoming elderly. Health geeks with rich health literacy invest in their health, using new technology but we observe quite a number of ordinary people with less health literacy. How can we inspire such uninterested people toward health investment or prevention before becoming sick?

The traditional approaches are from government, insurers or healthcare providers. National or local governments encourage members of their populations to improve health literacy and to receive health checks. Insurers may change member premiums and conditions, based on the members health status or lifestyle. Hospitals and medical doctors are in a good position to advise locals. However, governments tend to lack resources, insurers cannot reach non-members and hospitals cannot cover people who dont come to hospitals.

Governments can enforce obligations for ordinary individuals or businesses to take care of their health. A typical example of this is regulation for occupational health. While the requirement level and compliance level differs country by country, we observe employers obligations to secure employee safety and health in offices and factories in many countries. However, while a legal obligation is good at securing minimum standards, it is not good at encouraging best practices. An obligation is necessary but insufficient.

We need to use incentives for both individuals and businesses to realize better occupational health. A public-private partnership programme called Health and Productivity Management (H&PM) started in Japan six years ago. It encourages CEOs and company management to invest on a voluntary basis in their employees health for productivity and creativity purposes. The return of that investment is healthier employees with energy and enthusiasm and better evaluations from the labour market, capital markets, customers and society, all of which improves the value of the company. Now, more than 2,300 large companies and 35,000 SMEs in Japan have implemented H&PM.

External evaluation strengthens the return of investment. The Japanese Ministry of Economy, Trade and Industry (METI) and the Tokyo Stock Exchange select 35 listed companies from 26 sectors (based on the results of a yearly survey) for the H&PM stock selection competition. in addition, Nippon Kenko Kaigi, a large business and medical federation including the Japan Chamber of Commerce and Japan Medical Association, nominates 3,300 companies as certified H&PM companies.

So far, we have observed positive outcomes from H&PM. In the past five years, certified H&PM companies have outperformed other ordinary companies on the Tokyo Stock Exchange, according to an analysis by Tokyo Mitsubishi and Morgan Stanley Securities. Some institutional investors such as AXA Insurance have started considering H&PM as one element of environment, social and corporate governance (ESG).

While direct evidence is lacking, logically speaking, H&PM will have positive external effects on the rest of society and the economy, since healthier employees become healthier citizens and active consumers. Considering new business trends such as the SDGs, ESG or stakeholder capitalism, some companies are now more focused on these external effects than on the financial returns derived.

H&PM is not unique to Japan:Johnson & Johnson started H&PM decades ago and say one dollar invested generates 3 dollars in return.The US Chamber of Commerce issued a reportthat poor occupational health reduces GDP by 8.2%, 7%, 5.4% in the US, Japan and China respectively. In 2019, Business 20 (B20) included H&PM into its proposal to the G20. H&PM is a good strategy for improving occupational health in emerging economies with fewer initial resources. Sri Lanka started an H&PM awards programme in 2019.

It is fair to say that the rapid expansion of H&PM in Japan faces a unique challenge owing to the countrys labour shortage. As an ageing society, Japan lacks younger individuals as human resources, which makes recruitment a very important business issue. The same is true for the need to retain trained staff and convincing them not to resign. While H&PM works very well in this regard, such a labour shortage may happen in many countries as they age.

Increasing human productivity is one of the hot topics among global businesses amid rapid industrial structural change. I believe, H&PM is a new, positive strategy for realizing healthy longevity which will prove effective in many companies and economies.

Kazumi Nishikawa,Director, Healthcare Industries Division, Commerce and Service Industry Policy Group, Ministry of Economy, Trade and Industry of Japan

This article was originally published in World Economic Forum

Stay updated with all the insights.Navigate news, 1 email day.Subscribe to Qrius

Continued here:

As the World Lives Longer, Investment in Early Healthcare is Paramount - Qrius

Val McDermid: ‘Giving a seven-figure advance to a debut is a terrible thing to do to a writer’ – inews

CultureBooksThe 64-year-old's latest novel returns much loved characters, in a career that is remarkable for its longevity and consistency

Friday, 7th February 2020, 7:00 am

One of the most difficult things about writing a long-standing crime series is knowing when to stop. Val McDermid, the author of the best-selling Tony Hill and Carol Jordan books, admits there have been times when she has come close to pulling the plug.

I did wonder whether the last Tony and Carol book [2017s] Insidious Intent might be the final one, because where do you go after that? she says, referring to the shocking ending, which left Tony in prison and Carol out of the police force. But I was also sure that I didnt want to leave them on that note. I wanted a sense of hope.

That said, Im always very conscious that the series does have a shelf life. So far Ive never been bored with Tony and Carol but Im aware that if I have to be ruthless, I will be. I would never want readers to be picking them up in the hope that this one is the return to form.

i's TV newsletter: what you should watch next

This seems highly unlikely. McDermids career is remarkable for its longevity and its consistency. Her debut novel, Report for Murder, was published in 1987. She has since written 38 more books in a career that has also included short stories, non-fiction and an award-winning childrens book.

However it is crime, and particularly procedural crime, which remains her bread and butter. Her new novel, How the Dead Speak, is the 11th to feature Hill and Jordan. But McDermid also writes another crime series set in her home county of Fife, centring on cold-case detective Karen Pirie.

I enjoy those because cold cases allow for a very different tone, angle and direction, she says. All the blood happened a long time ago and the violence is off stage.

A confident voice

The mystery that launches How the Dead Speak happened off-stage, too: it begins with the discovery of human remains in an old convent and quickly builds into a dark, multi-stranded story, concluding in an expertly unfurled denouement.

Not that the 64-year-old is satisfied. What keeps me going with each book is the hope that I do better than the one before, she says, adding that shes her own harshest critic. Ive never written a book I was happy with.

She does, however, retain a soft spot for the first Hill and Jordan book, The Mermaids Singing, because it was so different to what I had done before. Finding the voices to tell that story gave me a bedrock of confidence.

For all those doubts, it is clear that McDermid, who has been married to academic Joanne Sharp since 2016, is at a great stage in her life. Apologising for the cold she is trying to shake off, she goes on to laugh about the fact I last interviewed her almost 20 years ago, soon after the birth of her son Cameron.

That baby is now about to go to university, she says. I know, its hard to believe.

Despite a busy workload, McDermid also finds time to relax, notably as the lead vocalist in a band, the Fun Lovin Crime Writers, alongside fellow authors Mark Billingham, Chris Brookmyre, Stuart Neville, Luca Veste and Doug Johnstone. The rock and blues group has played everywhere from local book festivals to Glastonbury and will perform at the Shepherds Bush Empire in March.

I really enjoy it because writers spend most of their time stuck in a cupboard looking at screens, so its nice to do something collaborative that gets us out of that cupboard and meeting people, she says.

Harsher industry

McDermid is conscious that publishing is a harsher industry than it was when she started in the late 80s. I took 10 years to be an overnight sensation, she says. These days, if you havent broken out by your third book, youre not going to have much of a career.

The industry fetishises novelty, but writers need time to develop. Giving a seven-figure advance to a debut is a terrible thing to do to a writer.

A great promoter of others work she curates the New Blood panel at Harrogates Theakston Old Peculier Crime Festival and recently announced the forthcoming publication of an anthology of Scottish writing she has little time for tropes and admits that she is always looking for something that suggests that the genre is changing.

I get very bored of reading books where the detective is a loner with no friends, she says. It just doesnt ring true. None of us fit that easily into a box; we all have jagged edges.

What Im reading now

Motherwell, By Deborah Orr. Its a remarkable memoir, the candour of it Having grown up working-class in Scotland, there are a lot of resonances.

What Im reading next

One of the 43 submissions I have for the New Blood panel at Harrogate. Between 50 and 70 debut crime novels will pass across my desk.

Continue reading here:
Val McDermid: 'Giving a seven-figure advance to a debut is a terrible thing to do to a writer' - inews

Going to museums regularly can have this surprising life benefit – Ladders

Artistic expression aims to do one of three things: normalize, distract or inform.Landscape with the Fall of Icaruspreaches the ubiquity of failure,The Persistence Of Memory arrests its audience with color and distortion, and The Wounded Deer explores the pleasure and poison of theology withpedagogicalstrangeness.

The value of pretty things goes beyond ontology, however. According to new research published Wednesday in the BMJ journal,those who frequent galleries, museums, and operas a few times a month or more decrease their risk of dying early by 31%, compared to those that do not.

While other health behaviors like smoking, alcohol, and exercise are undoubtedly bigger predictors of mortality, these leisure and pleasure activities that people dont think as a health-related activity do support good health and longevity,said Daisy Fancourt, an associate professor at UCLs Research Department of Behavioural Science and Health, and an author of the new study.If this (study) is added to the larger body of evidence, we are getting an increasingly rich picture on how arts can benefit health and its not about one single outcome. It can have wide-ranging benefits and support healthier lives lived longer.

The researchers began stitching their thesis together after reviewing a previously published study on aging comprised of over 6,000 English adults, 50 years of age or older.

Over the course of the first leg of the study, participants were polled on how often they attended artistic institutions. After all of the responses were submitted,the researchers from University College London conducted a follow-up study 14 years later, using The National Health Service of the United Kingdom in order to determine how many participants had died since the completion of the first analysis.Not only did engaging in artistic activities every few months or more yield a 31% risk decrease for early mortality, those that visited a gallery, museum or theater once or twice a year were additionally 14% less likely to die at an early age. From the report:

Part of the association is attributable to differences in socioeconomic status among those who do and do not engage in the arts, which aligns with research that suggests engagement in cultural activities is socially patterned.Receptive arts engagement could have a protective association with longevity in older adults. This association might be partly explained by differences in cognition, mental health, and physical activity among those who do and do not engage in the arts, but remains even when the model is adjusted for these factors.

Ultimately, socioeconomic factors accounted for 9% of the mortality correlation. Although mental health, mobility, and civic engagement had small roles to play in surging statistics, no independent component proved to be quite as material as the culture correlate that inspired the paper.

Art seemed to set off a therapeutic chain reaction. Those that reveled in it with any sort of regularity evidenced lower levels of stress, higher levels of ingenuity, adaptability and tended to report enjoying a robust social life. The authors also observed a greater sense of purpose within this demographic:He who has a why to live for can bear almost anyhow.

Which brings us back to the trinity of expression established in the introduction. I for one am exceedingly grateful for those who bore the minds to preserve bones and antiquities, but I wont try to articulate my gratitude more eloquently than the art historian, Georges Didi-Huberman. He wrote, In each historical object all times encounter one another, bifurcate, or even become entangled with one another.

Whatever the form, things made by human hands cant help but project values and solace. We can all relate to the agony of being, and we can all benefit when its finely expressed.

See more here:

Going to museums regularly can have this surprising life benefit - Ladders

Great Storytelling: It Pulls At Our Heartstrings And Holds Communities Together – Mountain Journal

It's a role that longevity and spending life in place has bequeathed him though don't be fooled. He's not very old. He still hikes into the mountains with his grandson on autumn hunts.

When McMillion says that Livingston is my kind of town the statement is more than a declaration of nostalgia for small-town America where heart-felt empathy for the past doesnt hold as much currency as it used to. Livingston has a reputation for defiance. It welcomes newcomers with open armsespecially those willing to buy the first round of drinks at the bar and yet it collectively sneers at anyone who dares move there, asserting a boastful intent to change the local culture.

Livingstoneans do not believe their little burg needs much improvement and the attitude serves as a sharp contrast to whats playing out today in the large booming neighbor on the side side of a mountain pass crossed by Interstate 90: Bozeman. Livingstoneans know they don't need unscrupulous developers to teach them what it means to live in a place that's "arrived" as a worthy destination.

McMillion, being a sound example of a local kid done good by his town in adulthood, is perhaps a model for the maxim that in order to fully appreciate the place that brung you along you need to leave it for a while to get ones head straightened out. After graduating from Park High School, he did two things. He got a degree in English from the University of Montana and traveled around the world.

But home kept calling him home and once he returned to Livingston, a railroad town and gateway to Yellowstone Park located along the Yellowstone River, he served as a longtime reporter for The Bozeman Daily Chronicle. It was out on thetrail of covering environmental stories, including crossing paths during the 1988 Yellowstone fires, that we became friends, setting aside the hard-wired drive to out-scoop one another.

Important to point out about Livingston is that its authentic character speaks to authentic people who go by the beat of their own drummers. The local yokels, unimpressed with anyone who projects airs, do not need outsiders validating what they do or don't do. Over the last half century, along the prospect of being able to be treated as just another person free of stalking sycophants, has attracted people of enormous talent who come to Paradise Valley and Livingston and want to be left alone. If the names McGuane, Brokaw, Bridges, Fonda, Harrison, Chatham, Hjortsberg, Kidder, Brautigan, Keaton, Peckinpah, Cahill, Peacock, Quaid and Ryan, among others, ring bellsand you appreciate their artthen you comprehend the reference and, if you dont, dont worry because you probably never will.

Following in their wakes have come new generations of world-class writers, photographers, flat artists, sculptors, playwrights and filmmakers. To have such a constellation descend upon your town could be paralyzing for a local writer yet McMillion has proved himself worthy to be counted in their company.

Montana Quarterly and non-profit Mountain Journal share these values. In this age in which America is being dumbed down by shameless purveyors of alternative facts, whose false assertions are going unchallenged, and as newspapers struggle for survival and perish, honest storytelling rooted in truth matters more than ever.

When we make a strong recommendation like this, that you supportMontana Quarterly by purchasing an eminently affordable subscriptionand maybe a second one for your kids or grandkids so that they will know the delights of tactile media arriving in real tactile mailit isnt out of some misguided sense of nostalgia. We also suggest you buy a subscription for any newcomer to the state whom you suspect might not quite understand that we do not want to become "the next" Portland, Denver, Bend, Oregon or Vail.

Montana Quarterly has earned your patronage and youll look forward with delight to each new issue. In addition to supporting the Quarterly there are other publications, below, operated by mutual friends of Scott and me. This is in addition to, whenever you have theopportunity, alsothink of local booksellers. Indeed, we vote our values whenever we open our wallets.

McMillion, right, with the late great Livingston-based novelist and non-fiction writer William "Gatz" Hjortsberg. In recent years Livingston has coped with the painful passing of Hjortsberg, Jim Harrison, Margot Kidder, Peter Fonda and Russell Chatham. Photo courtesy John Zumpano

A MoJo Chat With Scott McMIllion of Montana Quarterly

Todd Wilkinson: You are a seasoned journalist and author. Whats the most satisfying thing about publishing your own magazine?

Scott McMillion: Probably working with young writers. Over the past few years, weve lost a lot of virtuoso writers whose work has appeared in the Quarterly. Jim Harrison, Ed Dobbs and Gatz Hjortsberg, most notably.

I miss those guys, but I also cherish working with young writers like Todd Burritt, Sarah Rau Peterson, Alexis Bonogofksy, Adam Boehler and many others. I also work with writers who, like me, arent exactly spring chickens, like Kim Zupan, but Id probably never get to know them if I didnt have the magazine.

I meet a lot of young people through our annual Big Snowy Contests for young writers, which has helped a few of them jumpstart careers. And the number of venues for publishing just keeps shrinking, which adds importance to what we do.

Wilkinson: As national magazines have struggled, Montana Quarterly has maintained its spirited focus, sense for finding good stories and empathetic portrayals of regular people. Where does that instinct come from?

McMillion: The stories are actually fairly easy to find, mostly because Montanans tend to be a pretty chatty bunch. Everybodys got a yarn, and most folks are willing to tell it. Picking the right story, matching it with the right writer and photographer, is the challenging part. Its part instinct, part 30 years of experience, and mostly just a love of the state and its people. Our philosophy is pretty simple: Montana is a cool place that hasnt been screwed up yet. Weve got a community of writers, photographers and readers that want to keep it that way.

Wilkinson: This puts you on the spot but what are a few of your favorite pieces youve written and a few favorites by other writers in the Quarterly stable?

McMillion: Some of the favorites Ive written:A profile of the town of Saint Marie, which is the old Glasgow Air Force Base. Thousands of people lived there in the sixties, but now the place looks like a set from a zombie movie, with hundreds of houses and other buildings that havent seen a new shingle or a coat of paint in decades. A group of Sovereign Citizens the kind of guys who like to make their own license plates bought most of it for back taxes.

Spending a few days inside the mens meth prison in Lewistown. Talk about stories to tell! These are hard cases, but when photographer Thomas Lee and I walked in the gym, 200 cons stood up and sang You are my Sunshine. That stuff just doesnt happen every day.Covering the longstanding, expensive, and, sadly, probably futile effort to restore blackfooted ferrets to Montana. I got to hold one the rarest carnivores in the world in my lap. It was exciting enough that I didnt even mind the fleas crawling all over me.

This photo of a female mountain lion ran in the winter 2019 Montana Quarterly as part of story about new ways to study the elusive big cats. Photo courtesy Ryan Castle

Some of the other highlights:Sarah Rau Petersons hilarious and poignant depictions of ranch life in Eastern Montana. Shes not afraid to talk about ovine dingleberries and Im not afraid to publish what she says.Jeff Welschs story about the Blackfoot Challenge, which shows that ranches and predators can coexist, when smart people decide to make it happen.Pretty much anything Alan Kesselheim writes.And of course Tim Cahills gripping account of his own death in the Grand Canyon. But the big hoss is tough. He whupped death and lived to write about it.

Wilkinson: You wear your pride of Livingston residency on your sleeve. How does having a vantage from Livingston on the rest of Montana differ from, say, if you were based in Bozeman?

"Montana, Warts And All" is a volume featuring some of the magazine's most resonant stories in recent years.

Livingston is a little bit Bohemian and a little bit working class, and sprinkled with millionaires, but most people get along, though we do have a few soreheads. Were close to the mountains, close to the prairies, and the Yellowstone River is always a marvel. The wildlife lives among us, right in our yards. And while they say the wind blows now and then, if you put some rocks in your pockets youll probably stay earthbound.

As for Bozeman, if Id grown up there I dont think Id still be living there. I enjoy what it has to offerthe restaurants and the performancesbut the older I get the slower I move. I think that town has outgrown me. Livingston hasnt.

Wilkinson: In times like these, the late Russell Chatham said, art speaks to drama and anxiety in the air. Why does storytelling matter especially now?

McMillion: Storytelling has always been central to being human. Its how we figure out who we are and what we need to do. Our country is so divided and bitter these days, with half the nation accusing the other half of drinking the Kool-Aid.

At Montana Quarterly, we try to focus on what unites us and excites us instead of what divides us. We find a curiosity, a marvel, a marvelous person. Then we tell that story. I think it matters more than ever.

Remember: Support Your Local Newspaper. It plays a vital role in covering issues that matter to your community. Of course, if you have it in your heart, Mountain Journal is profoundly grateful for your support too. It is the only thing that enables us to exist.

Here is the original post:

Great Storytelling: It Pulls At Our Heartstrings And Holds Communities Together - Mountain Journal

Dearborn Heights woman who has worked for every city administration retires after 48 years at City Hall – Dearborn Press and Guide

Last week, Janet Kalczynski stepped down from her job as a payroll specialist at Dearborn Heights City Hall.

Big deal, you say? It is, when you realize that 6045 Fenton became her work address when Melanies Brand New Key topped the charts at legendary Detroit/Windsor radio powerhouse CKLW, and this newspaper was called the Dearborn Heights Leader.

Kalczynski was all of 20 years of age when her city career began on Dec. 15, 1971. Her first job, a bookkeeper for then-City Treasurer James Greenlaw, came with an annual salary of $7.687. After a few years, she crossed the hall to the Comptrollers Office, where she spent the bulk of her 48 years of employment.

While its on trend to job jump in todays society, Kalczynski who has worked with all eight Dearborn Heights mayors credits her longevity to her true love of her job and the people with whom shes worked.

My bosses were bosses and you have to answer to them, but everyone has always been so nice here and its always been a team effort, she said. Its hard to go away because of the camaraderie.

Kalczynski daughter of the late city councilman Tom Wayne, and wife of retired firefighter Larry Kalczynski attended Schoolcraft College in a short-lived pursuit of a law enforcement degree something unheard of back then. She had been working for Michigan Bell when she became aware of the job opening at City Hall.

My dad knew about the opening and it interested me, she said. Back then, the job requirements werent that stringent. You didnt need to take a testthings have obviously changed since then, but Ive loved every minute Ive been here.

One of her bosses, now-retired Comptroller Don Barrow, said her infectious laugh and work ethic come immediately to mind when he thinks about Kalczynski.

Janet's bubbly personality always made it a pleasure to come to work. She was dedicated to her job as much as she was to her family, Barrow said. The City of Dearborn Heights will surely miss this gem of an employee.

A Divine Child graduate, the former Janet Wayne began her time with the city using pencils, paper, and typewriters, and left immersed in the digital world, using software technology that dramatically cut task completion times.

Janets career is remarkable, said Human Resources Department Director Elisabeth Sobota-Perry. In 1971, women working full-time wasnt as common as it is now. Janet married an eventual firefighter, raised a family, juggled it all, and is able to retire on her own terms.

Kalczynski is always positive, happy, and very generous, Sobota-Perry added, and is a role model for newer, younger employees.

It should be noted that retirement is a foreign concept to the 68-year-old mother of three and grandmother of five. She will remain a part of the city workforce, this time in a part-time capacity, as she transitions to shelving books at Caroline Kennedy Library.

When you go to work, make it a job you dont mind getting up in the morning for. Get up, get in there, and get to work, Kalczynski said when asked her advice for young people entering the workforce. Yes, youre going to have bad days and chaos, but when all is said and done, youll have a great sense of accomplishment that makes you feel good about yourself.

View original post here:

Dearborn Heights woman who has worked for every city administration retires after 48 years at City Hall - Dearborn Press and Guide

The Human Side of Nuclear Weapons Issues in the FY20 Defense Bill – All Things Nuclear

Tonight, President Trump is expected to sign the National Defense Authorization Act (NDAA) at Joint Base Andrews, a defense budget bill totaling a stunning $738 billion. Much attention has been given to the many ways that Democrats lost out on progressive priorities in this bill. The nuclear arms control and disarmament community lost hard-fought battles over issues like the low-yield warhead, and overall spending levels on nuclear weapons systems.

UCSs President Ken Kimmel put out an important statement on these issues, urging members of Congress to vote no on this dangerous bill. But many nuclear weapons-related issues have been flying under the radar, especially those relating to the communities directly impacted by nuclear weapons production and testing. Heres a run-down of the issues nuclear policy wonks might have missed in their analysis of the NDAA.

Runit Dome (Source: US DOD)

The House version of the NDAA included a call for the Secretary of Energy to produce a comprehensive report on the health and environmental impacts of Runit Dome in the Marshall Islands: a massive unlined pit on Runit Island that holds waste and debris from 67 US nuclear tests on the islands, covered by a cracking, leaking concrete dome. The LA Times offers an excellent analysis of this issue.

The required elements of the report largely made it through the conference process intact, but the Senate removed some of the more sweeping provisions. These include a study of the physical health impacts on Pacific Islanders resulting from US nuclear testing activities in the Marshall Islands, and a call for a plan to remove the radioactive contaminants from the dome and relocate them to a more stable location.

For the Marshallese, who for decades have been fighting for proper recognition of the harms to their country and population, as well as adequate compensation, clean-up, and health care access, the call for a comprehensive study as outlined in the original House version would have been a step in the right direction. But the Republic of the Marshall Islands National Nuclear Commission stated: given the Senate-amended version of the bill, its difficult to see how the report would produce any new and useful information beyond what has already been done by the DOE, which has fallen short of satisfying Marshallese concerns.

In addition to working to prevent radiation leaks from the dome, the Marshallese are also fighting for, among other things, adequate studies and clean-up of other islands, proper compensation for health and environmental consequences and tests, and improved access to health care. So the dome itself is really just the tip of the radioactive iceberg. Much more work needs to be done by the US government to address their assault on the Marshallese people with these nuclear tests.

Atomic Veterans are the soldiers that were present at the USs nearly 200 atmospheric tests in the Marshall Islands and Nevada, as well as those that had to clean up the waste left behind from tests. The House version of the NDAA included a provision to create a Medal of Recognition to Atomic Veterans. The provision was taken out in conference and did not make it through to the final bill. This is a terrible shame and, in my opinion, a great sign of disrespect to the thousands of surviving atomic veterans.

In response to this decision, Keith Kiefer, National Commander of the National Association of Atomic Veterans, stated:

The National Association of Atomic Veterans has long said The Atomic Veterans seek no special favor, simply justice.

The most current Atomic Veteran count from the Defense Threat Reduction Agency (DTRA) sits at 550,000 individuals. Until 1996 these individuals were under an oath of secrecy, not being able to talk with their doctor or family members without risking imprisonment and/or civil fines. These individuals were left to suffer in silence. The Atomic Veteran was used in various roles of support, study of the physical, psychological and readiness effect(s) when using nuclear weapons. None of these men were given informed consent while participating in these activities.

If nuclear weapons were like conventional weapons, many of these veterans would have had evidence of physical injury and be eligible for a purple heart medal. Moreover, were it not for the oath of secrecy these veterans would have received service medals while still in the service. Most of these veterans longevity and quality of life have been shortened. Creation of and issuing an Atomic Veteran Service Medal would correct the injustice of not recognizing the sacrifice and contributions these veterans have made on behalf of the country. Of equal importance to the families whose veteran is no longer with us, is the recognition that their loved ones sacrifice and contributions were not in vain.

Though Congress created a certificate of recognition for Atomic Veterans, many feel that this simply does not carry the same weight as a medal. In seeking a medal of recognition, Atomic Veterans are asking for parity with other veterans that they may receive equal recognition for their sacrifices to their country.

Congress established the Radiation Exposure Compensation Act (RECA) in 1990 and expanded it in 2000 to provide compensation to people harmed by nuclear atmospheric testing (Downwinders and Atomic Veterans) and uranium workers (miners, millers, core drillers, ore transporters, and remediation workers). Though an important program overall, RECA is severely flawed, largely because many communities directly impacted by testing and uranium mining are left out of the program and therefore ineligible for compensation. These include many regions affected by testing, the veterans who cleaned up atomic waste after tests, and uranium industry employees who worked in facilities after 1971. Legislation has been introduced to address this (H.R. 3783 and S. 947), which many activists in these communities are working hard to support.

The NDAA sought to begin addressing these concerns in two ways:

Currently RECA is set to expire in 2022. H.R. 3783 and S. 947 would extend RECA until 2045; that additional time is sorely needed. Tina Cordova shares: Imagine the Downwinders of New Mexico have been denied access to RECA and the much needed health care coverage for 29 years and now we are facing a sunset provision. Bills have been introduced for 9 years to amend RECA to include the New Mexico Downwinders and yet not a single hearing in the House. Nuclear policy groups should pay attention to this upcoming deadline and support the communities advocating for these bills.

This NDAA authorized roughly $5.5 billion for Defense Environmental Cleanup of nuclear weapons waste sites like Hanford, Los Alamos and Oak Ridge Reservation. This is a roughly $100 million reduction from FY19 NDAA authorization levels. Clean-up budgets should be increasing, not decreasing, because the longer it takes to clean-up these sites, the longer workers and nearby residents are being exposed to dangerous nuclear and hazardous material. The good news is that the Energy + Water Appropriations bills allocate $6.255 billion for Defense Environmental cleanup, well above FY2019 levels.

Whats also notable here is that the $5.5 billion for clean-up represents nearly a quarter of the NDAAs whole discretionary budget for Atomic Energy Defense Activities, including all of weapons activities and non-proliferation. As the United States continues to increase spending on nuclear weapons, it should not forget that cleaning up the waste from the long history of producing weapons remains an extremely costly problem with no reasonable solution in sight, while communities and the environment continue to be poisoned by radioactive, toxic and hazardous pollutants.

Don Hancock notes that the NDAA does include new Senate language to require submission to Congress with the annual Budget Request a report on the costs of meeting legal agreement milestones at sites. The Request never includes sufficient funding, but activists have long advocated for DOE to have to admit to the significant shortfalls in the request.

Congress established the Defense Nuclear Facilities Safety Board (DNFSB) in 1988 to provide independent oversight for Department of Energy nuclear facilities to ensure their safety, as well as the safety of the public and workers. Watchdog and grassroots activist groups near nuclear sites have been fighting for over a year to ensure that the DNFSB retains its oversight capabilities. In 2018, the Department of Energy issued Order 140.1, which has the potential to severely constrain the Safety Boards access to information, facilities, documents and personnel.

Activists were glad to see a House provision largely remain in the final bill, which ensures the DNFSB has the full access they need. This is an important win for workers and nearby residents, allowing the Board to carry out its responsibilities to monitor nuclear sites and ensure public safety.

The nuclear policy community is also concerned about the requirement for the NNSA to produce 80 new plutonium pits per year starting in 2030, a significant increase over the current production capacity at Los Alamos National Laboratory (LANL) in New Mexico. The new production would take place at expanded LANL facilities and at the Savannah River Site in South Carolina. In addition to posing an arms control problem by supporting the production of new warheads in addition to refurbishing existing ones, these programs pose potential risks to the workers and nearby communities.

LANLs pit production program has been shut down many times, most recently from 2013 to 2016, over chronic safety concerns. Even after re-opening, an April 2019 report from the DOE and a November 2019 letter from the DNFSB highlight continuing major safety concerns.

Savannah River Site poses novel risks, as the site has never before produced pits, and is now being required to do so on a very expedited schedule, requiring the repurposing of the partially constructed Mixed Oxide Fuel Fabrication Facility, at which there were many construction problems. The combination of these issues (not even taking into account clean-up currently taking place at SRS) is a recipe for mistakes and accidents that could put people in harms way. A recent Institute for Defense Analyses report states that the current plan to produce 80 pits per year in the given timeline is extremely challenging, if not impossible, and poses many risks. In fact, they state No available option can be expected to provide 80 ppy [pits per year] by 2030. The DOE has not indicated how it will address this.

For more information on Runit Dome, please contact Rhea Moss-Christian, Chair of the Republic of the Marshall Islands National Nuclear Commission (NNC).For more information on the National Association of Atomic Veterans, contactKeith Kiefer, National Commander. For more information on RECA, contact Tina Cordova, Director, Tularosa Basin Downwinders Consortium or Joni Arends, Director, Concerned Citizens for Nuclear Safety. For more information on the nuclear waste clean-up budget or the oversight of nuclear facilities, contact Don Hancock at the Southwest Information and Resource Center. For more information on plutonium pit production, contact Jay Coghlan, Executive Director at Nuclear Watch New Mexico.

Posted in: Nuclear Weapons Tags: atomic veterans, fissile material, marshall islands, ndaa, nuclear weapons, pit production, plutonium, waste clearnup budget

Support from UCS members make work like this possible. Will you join us? Help UCS advance independent science for a healthy environment and a safer world.

The rest is here:

The Human Side of Nuclear Weapons Issues in the FY20 Defense Bill - All Things Nuclear

DANA D. KELLEY: In the beginning … – NWAOnline

Of all the national holidays we celebrate, Christmas is the most ancient, pre-dating our American genesis by about 14 centuries as a Christian celebration. Some of the associated lore goes back nearly another millennia as part of the Roman winter solstice festival of Saturnalia.

Longevity adds a distinct weight to Christmas; it's the singular season during which we sing songs, read verse and prose, and carry on customs from hundreds and hundreds of years ago.

The world has changed immensely since America's inception in the 18th century. We can scarcely conceive the true magnitude of its changes delving back five and 10 times further into human history. Life at the time of the Christ-child's birth is essentially beyond our imagination.

Christmas is old and resilient, and also uniquely transcendent in a geopolitical sense. For more than two billion people across 160 countries, it's the signature holiday and/or holy day of the year.

Given the enormity of its proportions, religiously and culturally, it's natural to view Christmas through a grotesquely oversized "big deal" lens. Besides being the consummate event at the core of the world's largest religion, it is master of the annual almanac. No day has more than 24 hours, but December 25 looms largest by every other measure.

With its trappings and gift traditions, it dominates the retail economy; indeed, nearly every shopping and buying experience in the fourth quarter is "Christmatized." It commands even greater regality in Christian denominations, organizations and churches.

Christmas has ubiquitous awareness and near-universal adoption in the U.S.: 90 percent of Americans will celebrate next Wednesday.

Add all the religious pomp and circumstance to the retail circus and chaotic commotion, and there's not a superlative adjective big enough to accurately describe its predominance.

That's our reality today. There is simply so much to do and be done: decorations to be put up, gifts to be bought and wrapped, parties to attend, cards to send, dinners to be made, families to visit. From musical presentations and theatrical productions to parades and lighting displays to work functions and church services, there's hardly a spare moment to give--or think.

But we need a little thought this Christmas, perhaps more this year than in many recently past. We need to remember not only what Christmas was at its start, but how it unfolded.

Whether you believe in the divinity of the Nativity or not doesn't change the details of its story, and the accompanying significance of those particulars.

The notion of God sending a Messiah to Earth via a poor couple in a stable runs counter to every "big deal" instinct of our consumerist consciousness and social hierarchy today. The point that Christmas first came to the "have nots" is a lost fact that desperately needs resurrection.

There were important places and people back at that time. The Jewish temple in Jerusalem was imposing and revered; religious officials were pious and ceremonial and held in high esteem. The Roman Empire erected palaces from whence it ruled and taxed the people, and magistrates and consuls wielded significant power and influence.

Yet it's revelatory and telling that in the story of the first Christmas, the good news of great joy to all wasn't channeled through a high priest or Caesar. On the contrary, it was proclaimed by word of mouth starting with lowly shepherds, who were arguably near the lowest rung of society in those parts.

In the beginning, Christmas circumvented the rich and famous and powerful. It's a story of ordinary people, in less than optimum conditions, dealing with stressful situations but still rising to the occasion. The faithful understand that stripping away of worldly pretense as reflective of our common humanity as creatures of God.

How an event so small and remote and disconnected from the social, religious and political order and structure of the day could wind up eventually eclipsing it does seem, well, miraculous.

There is also an e pluribus unum characteristic of Christmas that endears its spirit to a democratic people. It's one holiday, invitational to all, out of which many can approach, enjoy and share.

Few examples testify to the unifying potential of Christmas more profoundly than the impromptu "truce" among entrenched opposing troops on the western front in the early months of World War I.

Following a Christmas Eve of carol-singing across the lines, some German soldiers rose from their trenches unarmed the next morning, and called out "Merry Christmas" in English. The British, initially wary of trickery, responded in kind and the Great War was put on hold for a few hours while foot-soldiers exchanged gifts and good tidings.

Miracles of the heart can happen anytime, and we never know how far their resulting ripples can reach. Or how deeply they might reverberate across space and time.

Christmas reminds us to pay more attention to them, inspires us to be more open to them. Christmas instructs us to look for them, in keeping with the timeless truth that he who looks will find.

May you seek and find Christmas this year in little places and ways you never expected.

------------v------------

Dana D. Kelley is a freelance writer from Jonesboro.

Editorial on 12/20/2019

Print Headline: In the beginning ...

Read more here:

DANA D. KELLEY: In the beginning ... - NWAOnline